✦ LIBER ✦

PCN1 TOLERABILITY OF FIRST-LINE TREATMENTS OF LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER (NSCLC):A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON

✍ Scribed by SJ Edwards; N Welton; J Borrill

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN11 GEFITINIB COMPARED WITH DOUBLET CH

✍ SJ Edwards; N Welton; J Borrill 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Cost-Effectiveness of First-Line Treatme

✍ Eijgelshoven, I.; Verduyn, S.C.; Bhatti, T.; Bexelius, C.; Jansen, J.P. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN43 COST COMPARISON OF ERLOTINIB VERSU

✍ S Ravera; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PCN44 COST COMPARISON OF ERLOTINIB VERSU

✍ J Castro de Carpeño; AJ Castro-Gómez; S Walzer; J Ray 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

A multicenter phase II study of docetaxe

✍ Raez, Luis E.; Santos, Edgardo S.; Webb, R. Timothy; Wade, James; Brito, Roger A 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 324 KB

A cross-market cost comparison of erloti

✍ Nuijten, Mark J.C.; de Castro Carpeño, Javier; Chouaid, Christos; Vergnenègre, A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 375 KB